Thanks Gerry, some common sense there.

" There’s a virus that the CDC currently estimated has killed between
20,000 and 45,000 people in the United States -- influenza. But only half
the country gets that vaccine.

There’s only 14 deaths [in the U.S., as of Friday afternoon] from COVID-19,
but everybody would get a vaccine now.

The point being: We’re not very good at assessing risk."

I think we are up to 40 dead now from this Wuhan flu.
-------------
Max
Charleston SC


On Fri, Mar 13, 2020 at 12:24 PM archer75--- via Mercedes <
mercedes@okiebenz.com> wrote:

>
>
>
> Philly vaccine pioneer: We can’t rush a coronavirus vaccine | Q&A
>
>
> At a White House news conference Tuesday, Anthony Fauci, the head of the
> National Institute of Allergy and Infectious Disease, told President Donald
> Trump a coronavirus vaccine would likely not be available within the next
> year or two. Trump responded: “I like the sound of a couple of months
> better.”
>
> But a vaccine is not going to be available in the next couple of months,
> and according to Dr. Paul Offit, that’s appropriate. Offit, director of the
> Vaccine Education Center at Children’s Hospital of Philadelphia, is the
> co-developer of the rotavirus vaccine. It took roughly 26 years to perfect
> that protection against a disease that, according to the Centers for
> Disease Control and Prevention, was the leading cause for severe diarrhea
> in children before the vaccine’s introduction in 2006.
>
> Why is it unrealistic to expect a vaccine for coronavirus in a few months?
>
> Nobody’s ever seen this virus before. Therefore, if you’re interested in
> making a vaccine, you first had access to that virus only a couple months
> ago. That’s not long.
>
> [To make a vaccine] you first need to make a decision as to what approach
> you want to take. Then you have to do extensive animal model testing to
> make sure that the approach that you’ve taken is safe in animals, and that
> it induces an immune response which would likely be protective. Then you
> gradually do studies in people to make sure it’s safe, and then to make
> sure that it induces an immune response. That takes time, a lot of time,
> typically years. Then and only then, are you ready to put it into people to
> see whether or not it works in an outbreak situation.
>
> In 2018, after the World Health Organization declared an Ebola outbreak in
> the Democratic Republic of Congo, there was an experimental vaccine very
> quickly.
>
> I think people got fooled by Ebola. When the outbreak occurred in West
> Africa and we had a vaccine pretty much that rolled off shelf within weeks,
> people thought, Ha! That’s easy.
>
> But what they didn’t realize is people have been working on an Ebola
> vaccine for 20 years. They’ve done the animal model testing. They’ve done
> the testing to make sure that the vaccine was safe and was immunogenic.
>
> But that’s not true here. This is a new virus. So we’re starting from
> scratch.
>
> What is it about this virus that makes people confident that a vaccine
> will be available?
>
> I don’t know. You know, I’d say about 15% to 20% of the respiratory
> infections that we see in our hospital in the winter months are [types of]
> coronavirus. This is a virus that has been around for 50 years.
>
> But here are these three newer strains of coronavirus — MERS, SARS, and
> now this COVID-19. The first two viruses, SARS and MERS, have come and gone.
>
> I think this [COVID-19] virus likely will come back because it’s
> different. If you were infected with SARS or MERS viruses, you were sick.
> And it’s very easy to tell who was sick and who wasn’t. You could then
> quarantine those people — put a moat around them, if you will — so that
> they wouldn’t infect others. So those infections quickly died out. This
> virus is more like flu. It spreads in a similar manner to flu by
> respiratory droplet. It’s about as contagious as flu. It has the same set
> of symptoms as flu. And I think in the end, frankly, it’s going to have the
> same mortality rate as flu.
>
> There are certainly human studies showing that if you’re infected with a
> coronavirus — meaning one of the typical coronaviruses — you can have
> immunity to that strain for at least a year and probably longer. That’s
> encouraging. If natural infection can protect you, then it’s encouraging
> that it can produce an immune response which is protective and which you
> should be able to mimic with vaccination.
>
> Vaccine development is tightly regulated. How much of that is about safety
> vs. red tape?
>
> If you’re going to be testing this in otherwise healthy people who are
> very, very unlikely to die from this infection, you better make sure it’s
> safe. So you want those regulations in place.
>
> An example is the dengue vaccine. When it was tested in Latin America and
> Philippines, it was found to actually increase your risk of dengue shock
> syndrome. Children who were less than 9 years of age, who had never been
> exposed to the virus before, were actually more likely to be hurt by the
> vaccine than helped by it. Now, you only knew that from doing large
> clinical trials with tens of thousands of people.
>
> The history of medical breakthroughs is littered with tragedy. You want to
> make sure that things are safe.
>
> What do you think is behind the apparent willingness to skirt the rules to
> rush a vaccine?
>
> I think that because we falsely overrate, or incorrectly rate, what the
> mortality rate is, we’re willing to accept that things will be rushed
> through. In fact, coronavirus doesn’t have a high mortality rate.
>
> There’s a virus that the CDC currently estimated has killed between 20,000
> and 45,000 people in the United States -- influenza. But only half the
> country gets that vaccine.
>
> There’s only 14 deaths [in the U.S., as of Friday afternoon] from
> COVID-19, but everybody would get a vaccine now.
>
> The point being: We’re not very good at assessing risk.
>
>
> https://www.inquirer.com/health/coronavirus/coronavirus-covid-19-vaccine-trump-paul-offit-20200306.html
>
> Gerry
> ........................................................................
>
>
> _______________________________________
> http://www.okiebenz.com
>
> To search list archives http://www.okiebenz.com/archive/
>
> To Unsubscribe or change delivery options go to:
> http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
>
>
_______________________________________
http://www.okiebenz.com

To search list archives http://www.okiebenz.com/archive/

To Unsubscribe or change delivery options go to:
http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com

Reply via email to